Immunovant, Inc. (IMVT): $15.50

0.89 (+6.09%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add IMVT to Watchlist
Sign Up

Industry: Biotech


Ranked

of 493

in industry

Immunovant Inc (IMVT) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering IMVT.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
10 $55 $26 $39.1 $15.63 150.16%

The Trend in the Analyst Price Target


Over the past 63 days, IMVT's average price target has gone up $0.55.

IMVT reports an average of 107.2% for its upside potential over the past 119 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-05-08 10 55 26 39.10 16.76 133.29%
2021-04-25 10 55 26 39.10 15.44 153.24%
2021-04-17 10 55 26 39.10 15.42 153.57%
2021-04-10 10 55 26 39.10 15.68 149.36%
2021-04-03 10 55 26 39.10 16.85 132.05%
2021-03-20 10 55 26 39.10 17.00 130%
2021-03-13 10 55 26 39.10 16.99 130.14%
2021-03-06 11 55 26 38.55 13.51 185.34%
2021-02-27 11 55 26 38.55 15.78 144.3%
2021-02-20 11 55 26 38.55 18.09 113.1%
2021-02-13 11 55 31 39.45 22.21 77.62%
2021-02-06 11 67 31 42.55 24.15 76.19%
2021-01-30 11 67 49 58.27 39.03 49.3%
2021-01-23 11 67 49 58.27 42.19 38.11%
2021-01-16 11 67 49 58.27 44.10 32.13%
2021-01-09 11 67 49 58.27 49.60 17.48%

IMVT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.35 4 5 1 0 0 10

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • The variance in analysts' estimates of IMVT is less than 11.06% of all US stocks.
  • Immunovant Inc's upside potential (average analyst target price relative to current price) is greater than 88.06% of all US stocks.
  • IMVT has a greater number of analysts covering the stock than 85.26% of Pharmaceutical Products stocks.
  • Immunovant Inc's average analyst price target is greater than 70.51% of Pharmaceutical Products stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Immunovant Inc are CBAY, ATRA and ZGNX.

What is the outlook for IMVT? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5961 seconds.